跳轉至內容
Merck
  • Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9.

Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9.

Journal of medicinal chemistry (2007-02-22)
Charles W Locuson, Peter M Gannett, Robyn Ayscue, Timothy S Tracy
摘要

Several laboratories have demonstrated that activation of drug metabolism by P450s may occur via a mechanism that resembles allosterism from an enzyme kinetic standpoint. Because the effector drug binding site may be located in the same P450 binding pocket where the drug substrate is located, the ability to find and characterize novel effectors (aka heteroactivators) will prove to be important in probing the mechanism of activation. We have used analogues of the prototypical CYP2C9 heteroactivator dapsone to validate a simple docking method that can be used to predict heteroactivators based on ligand binding location in a P450 crystal structure. As proof of concept for the described docking method, a protocol was developed to discover potential heteroactivators from a virtual chemical library through efficient sorting of >40,000 compounds. One of the top-scoring compounds identified was verified to be a CYP2C9 heteroactivator in vitro, and it possessed activity similar to dapsone.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
对氨基苯磺酰胺, ≥98%
Sigma-Aldrich
磺胺嘧啶, 99.0-101.0%
Sigma-Aldrich
二苯并噻吩, 98%
Sigma-Aldrich
二苯硫醚, 98%
Sigma-Aldrich
4,4′-磺酰基二苯酚, 98%
Sigma-Aldrich
磺胺二甲基嘧啶, 99.0-101.0% (on dried basis)
Sigma-Aldrich
二苯并噻吩, ≥99%
Supelco
磺胺甲噁唑
Sigma-Aldrich
对氨基苯磺酰胺, puriss. p.a., ≥98% (calc. to the dried substance)
Supelco
磺胺甲噁唑, VETRANAL®, analytical standard
Supelco
对氨基苯磺酰胺, VETRANAL®, analytical standard
Supelco
磺胺二甲基嘧啶, VETRANAL®, analytical standard
Supelco
二苯砜, PESTANAL®, analytical standard
Supelco
磺胺嘧啶, VETRANAL®, analytical standard
Supelco
氨苯砜, VETRANAL®, analytical standard
Supelco
二苯并噻吩, analytical standard